Idorsia Ltd. (IDRSF)
5.38
-0.02
(-0.37%)
USD |
OTCM |
Oct 02, 16:00
Idorsia EPS Diluted (Quarterly) : -0.5293 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5293 |
| March 31, 2026 | -0.2308 |
| December 31, 2025 | -0.3918 |
| September 30, 2025 | -0.4992 |
| June 30, 2025 | -0.0675 |
| March 31, 2025 | 0.2593 |
| December 31, 2024 | -0.5085 |
| September 30, 2024 | -0.5337 |
| June 30, 2024 | -0.6673 |
| March 31, 2024 | 0.1464 |
| December 31, 2023 | -0.7363 |
| September 30, 2023 | 1.091 |
| June 30, 2023 | -1.143 |
| March 31, 2023 | -1.288 |
| December 31, 2022 | -1.127 |
| September 30, 2022 | -1.258 |
| June 30, 2022 | -1.293 |
| March 31, 2022 | -1.207 |
| December 31, 2021 | -1.579 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.9087 |
| June 30, 2021 | -0.9126 |
| March 31, 2021 | -0.6925 |
| December 31, 2020 | -0.9424 |
| September 30, 2020 | -0.8909 |
| June 30, 2020 | -0.5204 |
| March 31, 2020 | -0.9319 |
| December 31, 2019 | -1.077 |
| September 30, 2019 | -0.9143 |
| June 30, 2019 | -0.9417 |
| March 31, 2019 | -0.8034 |
| December 31, 2018 | -0.818 |
| September 30, 2018 | -0.9217 |
| June 30, 2018 | -0.6808 |
| March 31, 2018 | -0.6868 |
| December 31, 2017 | 0.5698 |
| September 30, 2017 | -0.6047 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -0.944 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 2.050 |
| AC Immune SA | 0.026 |
| CRISPR Therapeutics AG | -0.9445 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -135.44M |
| Revenue (Quarterly) | 66.88M |
| Total Expenses (Quarterly) | 202.32M |
| Enterprise Value | 2.970B |
| Gross Profit Margin (Quarterly) | 72.13% |
| Profit Margin (Quarterly) | -202.5% |
| Earnings Yield | -30.69% |
| Normalized Earnings Yield | -24.51 |